Melissa McBurnie
Presidente en MetabloQ Pty Ltd. .
Perfil
Melissa McBurnie is currently the Chairman at MetabloQ Pty Ltd.
and the Director at Ankere Therapeutics.
She is also a Partner at Brandon Capital Partners Pty Ltd.
Dr. McBurnie has a graduate degree from the University of Adelaide and an MBA from the same institution.
Cargos activos de Melissa McBurnie
| Empresas | Cargo | Inicio |
|---|---|---|
Brandon Capital Partners Pty Ltd.
 Brandon Capital Partners Pty Ltd. Investment ManagersFinance Brandon Capital Partners Pty Ltd. (Brandon Capital Partners) is a venture capital firm founded in 2007 by David Fisher and Chris Nave. The firm is headquartered in Sydney, Australia. | Inversor de Capital Privado | 01/01/2008 |
MetabloQ Pty Ltd.
 MetabloQ Pty Ltd. BiotechnologyHealth Technology MetabloQ Pty Ltd. develops drugs for cancer treatment. It treats triple-negative breast cancer, prostate cancer and melanoma cancer diseases. The company was founded in 2016 and is headquartered in Melbourne, Australia. | Presidente | - |
Ankere Therapeutics
 Ankere Therapeutics BiotechnologyHealth Technology Ankere Therapeutics develops therapeutics for inflammatory diseases. The Australian company was founded by Stuart Pitson, Bernard Flynn. Bernard Flynn has been the CEO since incorporation. | Director/Miembro de la Junta | - |
Formación de Melissa McBurnie.
| University of Adelaide | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
Brandon Capital Partners Pty Ltd.
Brandon Capital Partners Pty Ltd. Investment ManagersFinance Brandon Capital Partners Pty Ltd. (Brandon Capital Partners) is a venture capital firm founded in 2007 by David Fisher and Chris Nave. The firm is headquartered in Sydney, Australia. | Finance |
MetabloQ Pty Ltd.
MetabloQ Pty Ltd. BiotechnologyHealth Technology MetabloQ Pty Ltd. develops drugs for cancer treatment. It treats triple-negative breast cancer, prostate cancer and melanoma cancer diseases. The company was founded in 2016 and is headquartered in Melbourne, Australia. | Health Technology |
Ankere Therapeutics
Ankere Therapeutics BiotechnologyHealth Technology Ankere Therapeutics develops therapeutics for inflammatory diseases. The Australian company was founded by Stuart Pitson, Bernard Flynn. Bernard Flynn has been the CEO since incorporation. | Health Technology |
- Bolsa de valores
- Insiders
- Melissa McBurnie
